View Nova Biomedical’s product lines ranging from hospital point-of-care measuring systems and hospital blood gas analyzers to biotech chemistry/cell analyzers and self-testing diabetes monitoring systems.
Webinars on timely topics such as POCT, critical care, clinical practice and regulatory updates, and common conditions including sepsis and hyperglycemia.
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art, whole blood, point-of-care and critical care analyzers, as well as providing the biotechnology industry with the most advanced instruments for cell culture monitoring. Nova is one of the fastest growing in vitro diagnostic companies in the world. Nova’s biosensor technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Nova employs over 1,100 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, France, Germany, Great Britain, Italy, Japan, and Taiwan. Certified by the International Organization for Standardization, Nova has manufacturing operations located in the U.S., Taiwan, and Brazil.
Nova Biomedical Launches New Veterinary Critical Care Analyzer Stat Profile Prime Plus VET : New technologies improve testing, animal care, and profitability
Nova Biomedical is pleased to announce the domestic and international launch of Stat Profile Prime Plus VET, the latest addition to the Stat Profile line of veterinary critical care analyzers. Prime Plus VET is the most comprehensive veterinary critical care analyzer, offering 22 critical care tests including regulated countries... Details
Nova Biomedical Launches New CE-Marked Critical Care Analyzer Stat Profile Prime Plus : New technologies improve and simplify testing
Nova Biomedical is pleased to announce that a new addition to the Stat Profile line of blood gas critical care analyzers, Stat Profile Prime Plus, has gained CE mark certification and is now available in all CE regulated countries... Details
Nova Biomedical Announces BioProfile® FLEX2 Cell Culture Analyzer Integration With the ambr® 15 cell culture Microbioreactor System from Sartorius Stedim Biotech
Nova Biomedical today announced a collaboration with Sartorius Stedim Biotech (SSB) for integration of the Nova BioProfile FLEX2 comprehensive cell culture chemistry analyzer with the ambr microbioreactor system. Under the terms of the agreement, technical experts... Details